CGGBP1 Human shRNA Plasmid Kit (Locus ID 8545)
CAT#: TL313955
CGGBP1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | CGGBP1 Human shRNA Plasmid Kit (Locus ID 8545) |
Locus ID | 8545 |
UniProt ID | Q9UFW8 |
Synonyms | CGGBP; p20-CGGBP |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | CGGBP1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 8545). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001008390, NM_001195308, NM_003663, NM_003663.1, NM_003663.2, NM_003663.3, NM_001008390.1, NM_001195308.1, BC052980, BC052980.1, BC005222, BC042194, NM_001008390.2 |
Summary | This gene encodes a CGG repeat-binding protein that primarily localizes to the nucleus. CGG trinucleotide repeats are implicated in many disorders as they often act as transcription- and translation-regulatory elements, can produce hairpin structures which cause DNA replication errors, and form regions prone to chromosomal breakage. CGG repeats are also targets for CpG methylation. In addition to its ability to bind CGG repeats and regulate transcription, this gene is believed to play a role in DNA damage repair and telomere protection. In vitro studies indicate this protein does not bind to methylated CpG sequences. [provided by RefSeq, Jul 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
CGGBP1 regulates CTCF occupancy at repeats
,Patel, D;Patel, M;Datta, S;Singh, U;,
Epigenetics Chromatin
,PubMed ID 31547883
[CGGBP1]
|
CGGBP1 regulates chromatin barrier activity and CTCF occupancy at repeats
,Patel, D;Patel, M;Singh, U;,
bioRxiv
[CGGBP1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...